RRC ID 84236
Author Horiuchi H, Watanabe A, Yaguchi T, Ban S, Otsuka T, Miyazaki H, Furuya R.
Title Superficial abdominal surgical site infection caused by Aspergillus welwitschiae: a case report.
Journal BMC Infect Dis
Abstract BACKGROUND:Aspergillus spp. are rare causes of surgical site infections (SSIs). Specifically, Aspergillus section Nigri, commonly identified as Aspergillus niger through morphological findings, has infrequently been reported as an abdominal SSI pathogen.
CASE PRESENTATION:An 86-year-old woman with a history of hypertension, chronic kidney disease, and atrial fibrillation who was taking 6 mg of prednisolone daily for rheumatoid arthritis was admitted to our hospital because of sudden abdominal pain. She was diagnosed with sigmoid colon perforation and underwent an open Hartmann operation on the day of admission. Subsequently, a superficial abdominal SSI was detected. Through analysis of the calmodulin gene, Aspergillus welwitschiae, which is classified within the Aspergillus section Nigri, was identified as the responsible pathogen. The minimum inhibitory concentration of voriconazole (VRCZ) was 2 mg/L. Surgical removal of the infected tissue and VRCZ administration was effectively used to treat the infection.
CONCLUSIONS:Given the reported low susceptibility of Nigri section species to azoles, identification and drug susceptibility testing of these fungi are highly important.
Volume 24(1)
Pages 990
Published 2024-9-17
DOI 10.1186/s12879-024-09919-4
PII 10.1186/s12879-024-09919-4
PMID 39289609
PMC PMC11406909
MeSH Aged, 80 and over Antifungal Agents* / therapeutic use Aspergillosis* / diagnosis Aspergillosis* / drug therapy Aspergillosis* / microbiology Aspergillus* / drug effects Aspergillus* / genetics Aspergillus* / isolation & purification Female Humans Microbial Sensitivity Tests Surgical Wound Infection* / drug therapy Surgical Wound Infection* / microbiology Voriconazole / therapeutic use
IF 2.688
Resource
Pathogenic eukaryotic microorganisms Aspergillus welwitschiae IFM 68753